Calcitriol FDA Link Generic

The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.

Also Known As:

Calcijex; Rocaltrol; 1,25 Dihydroxycholecalciferol; 1 alpha, 25-dihydroxy-20-epi-Vitamin D3; 1,25(OH)2-20epi-D3; 1,25-dihydroxy-20-epi-Vitamin D3; 20- epi- 1alpha,25- dihydroxycholecaliferol; Bocatriol; Calcitriol KyraMed; Calcitriol-Nefro; Decostriol; MC-1288; MC1288; Osteotriol; Renatriol; Silkis; Sitriol; Soltriol; Tirocal; 1 alpha,25 Dihydroxyvitamin D3; 1,25 Dihydroxyvitamin D3; 1,25 dihydroxy 20 epi Vitamin D3; Calcitriol Nefro; D3, 1 alpha,25-Dihydroxyvitamin; D3, 1,25-Dihydroxyvitamin; D3, 1,25-dihydroxy-20-epi-Vitamin; KyraMed, Calcitriol; MC 1288; 1 alpha,25-Dihydroxycholecalciferol; 1 alpha,25-Dihydroxyvitamin D3; 1, 25-(OH)2D3; 1,25(OH)2D3; 1,25-Dihydroxycholecalciferol; 1,25-Dihydroxyvitamin D3; 9,10- Secocholesta- 5,7,10(19)- triene- 1,3,25- triol, (1alpha,3beta,5Z,7E)-

Pharmalogical Action Categories:

Bone Density Conservation Agents
Calcium Channel Agonists
Vitamins

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Secosteroids: 22
      - Vitamin D: 33265
        Cholecalciferol: 4786
        Hydroxycholecalciferols: 25
        Dihydroxycholecalciferols: 2
        Calcitriol: 5322
    - Cholestanes
      - Sterols: 2245
        Cholecalciferol: 4786
        Hydroxycholecalciferols: 25
        Dihydroxycholecalciferols: 2
        Calcitriol: 5322
      - Cholestenes
        Cholecalciferol: 4786
        Hydroxycholecalciferols: 25
        Dihydroxycholecalciferols: 2
        Calcitriol: 5322
Lipids: 114793
- Membrane Lipids: 1591
  - Sterols: 2245
    - Cholecalciferol: 4786
      - Hydroxycholecalciferols: 25
        Dihydroxycholecalciferols: 2
        Calcitriol: 5322

Jolene Kay Berg Selected Research

Jolene Kay Berg Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure